Le Lézard
Classified in: Science and technology
Subjects: SVY, HSP

New ESSA Tier II Studies Show Newsela Products Accelerate Learning for Students across ELA and Social Studies


NEW YORK, Feb. 27, 2024 /PRNewswire/ -- Today, Newsela released the findings of four ESSA Tier II efficacy studies showing positive student outcomes for students who used Newsela products compared to their peers who did not. The results demonstrated gains equal to about 3 additional months of literacy growth in ELA and 10 additional months of social studies instruction.

The studies meet the Every Student Succeeds Act (ESSA) standards for "Moderate - Tier II" research. ESSA is America's primary education law that provides a framework for evaluating the effectiveness of educational programs. Tier II research evaluations are well-designed and well-implemented quasi-experimental studies. They compare a treatment group using a target program to a comparable comparison group and demonstrate a statistically significant effect on improving student outcomes. Newsela's recent studies showed consistent results of accelerating learning growth for students across race, ethnicity, gender, and language status.

"When students are given the knowledge and skill-building tools needed to become great readers and critical thinkers, that success is not just seen in the ELA classroom," said Dan Cogan-Drew, Chief Academic Officer of Newsela. "Our latest studies show that Newsela is building strong readers across subjects and the skill and strategy practice ingrained in our suite of products is contributing to real outcomes in the classroom."

Newsela is changing the way skills are practiced in the classroom, and that starts with putting relevant, real-world content and activities at the center of its products. Its content-rich literacy approach, based on the science of reading, helps students build key language comprehension skills like vocabulary, reasoning, and background knowledge that are critical to becoming skilled readers and, as these studies show, producing positive outcomes across subjects.

"Not only did our students show literacy gains after using Newsela ELA, but teachers had access to higher quality resources and better tracking of student achievement and progress," said Pamela Krebs, Dexter Community School Instructional Coach. "If we can simultaneously improve outcomes and take away some of the burden on teachers to find high-quality resources, that's a huge win as a district."

Findings: 

These studies include independent, third-party evaluations designed to align with What Works Clearinghouse (WWC) Standards With Reservations.

For more information visit www.newsela.com/about/research-and-efficacy/ 

About Newsela
Newsela is an education technology company dedicated to meaningful classroom learning for every student. Its products are purpose-built to inspire teachers, unlock student motivation, and drive long-lasting learning outcomes. From building student knowledge and skills in core subject areas to supporting daily instruction and assessment, Newsela helps teachers engage, support, and grow every learner.

SOURCE Newsela


These press releases may also interest you

at 02:34
Elbit Systems Ltd.  ("Elbit Systems" or the "Company") announced today that it was awarded an initial contract of approximately $37 million to supply Iron Fist Active Protection Systems (APS) to General Dynamics Ordnance and Tactical Systems...

4 mai 2024
UroGen Pharma Ltd. , a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced results from a new analysis of the ATLAS trial, which estimates using Kaplan Meier...

4 mai 2024
U.S.-based tech startup Iozera, in collaboration with the Government of Morocco, announces an initiative set to transform the AI industry. Iozera has announced the signing of a Memorandum of Understanding (MOU) for the establishment of a pioneering...

4 mai 2024
OKX, a leading Web3 technology company, has issued updates for May 3, 2024. OKX today announced that its Web3 Wallet is now...

4 mai 2024
UroGen Pharma Ltd. , a biotech company dedicated to developing and commercializing novel solutions that treat urothelial and specialty cancers, today highlights the results of a sub-analysis from a real-world patient cohort review of JELMYTO...

4 mai 2024
With a remarkable achievement of 81.556 billion yuan in operating revenue, marking an 11.74% increase from the previous year, and a net profit attributable to shareholders of 7.039 billion yuan, soaring by 27.21%, JA Solar hit historic highs in both...



News published on and distributed by: